John C. Inglis
John C. Inglis's purchase track record
How the stock did after each of John C. Inglis's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/30/2025 | AIG | $1K | -12.1% | -12.4% | +8.8% |
| 11/4/2025 | HBAN | $100K | +21.5% | +9.5% | +7.2% |
| 9/30/2025 | AIG | $1K | +10.2% | -3.1% | -2.4% |
| 8/8/2025 | AIG | $50K | -1.0% | -0.7% | +8.5% |
| 6/27/2025 | AIG | $895 | -7.3% | +3.4% | +12.3% |
| 3/31/2025 | AIG | $792 | -1.0% | -9.4% | +18.7% |
| 12/30/2024 | AIG | $787 | +20.4% | +19.2% | +5.1% |
| 11/26/2024 | AIG | $50K | +4.1% | +10.1% | -1.7% |
| 9/30/2024 | AIG | $520 | -0.4% | +20.0% | -2.6% |
| 6/28/2024 | AIG | $518 | -0.7% | -0.6% | +9.3% |
| 5/22/2024 | AIG | $50K | -5.3% | -4.3% | +11.5% |
| 3/14/2024 | AIG | $50K | -2.3% | -3.0% | +8.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
AIG analysts lower price targets while highlighting dividend appeal. Recent analyst reports from Wells Fargo and Keefe, Bruyette & Woods kept their coverage on AIG but reduced price targets to $83 and $90 respectively. At the same time, commentary highlighted AIG’s dividend yield of about 2.2% as attractive for income‑focused investors. A separate analysis noted the insurer’s exposure to rising war‑risk premiums and compared its Q2 performance favorably against other multi‑line insurers.
Transaction History
| HBAN | ▲ Buy | Grant | 1,280 | $0 | 10/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 1,057 | $0 | 7/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 10,523 | $0 | 5/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 22 | $0 | 4/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 1,059 | $0 | 4/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 893 | $0 | 1/2/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 92 | $0 | 1/2/2026 | View on chart |
| AIG | ▲ Buy | Open Market | 14 | $1K | 12/30/2025 | View on chart |
| HBAN | ▲ Buy | Open Market | 6,506 | $100K | 11/4/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 841 | $0 | 10/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 92 | $0 | 10/1/2025 | View on chart |
| AIG | ▲ Buy | Open Market | 15 | $1K | 9/30/2025 | View on chart |
| AIG | ▲ Buy | Open Market | 653 | $50K | 8/8/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 817 | $0 | 7/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 93 | $0 | 7/1/2025 | View on chart |
| AIG | ▲ Buy | Open Market | 11 | $895 | 6/27/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 9,404 | $0 | 5/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 831 | $0 | 4/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 127 | $0 | 4/1/2025 | View on chart |
| AIG | ▲ Buy | Open Market | 9 | $792 | 3/31/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 560 | $0 | 1/2/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 186 | $0 | 1/2/2025 | View on chart |
| AIG | ▲ Buy | Open Market | 11 | $787 | 12/30/2024 | View on chart |
| AIG | ▲ Buy | Open Market | 660 | $50K | 11/26/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 389 | $0 | 10/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 211 | $0 | 10/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 245 | $0 | 10/1/2024 | View on chart |
| AIG | ▲ Buy | Open Market | 7 | $520 | 9/30/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 263 | $0 | 7/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 226 | $0 | 7/1/2024 | View on chart |
| AIG | ▲ Buy | Open Market | 7 | $518 | 6/28/2024 | View on chart |
| AIG | ▲ Buy | Open Market | 635 | $50K | 5/22/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 10,073 | $0 | 5/1/2024 | View on chart |
| AIG | ▲ Buy | Open Market | 659 | $50K | 3/14/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 11,802 | $0 | 7/18/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HBAN Earnings Outlook and Valuation Concerns Highlighted
Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.
HBAN Earnings Outlook and Valuation Concerns Highlighted. Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.